Belinda Joan Lawford

Belinda Joan Lawford

Auto-generated profile, based on publicly available information

Belinda Joan Lawford

Centre for Health, Exercise and Sports Medicine, The University of Melbourne, Melbourne, Victoria, Australia

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2021 in Journal of Physiotherapy
Verified
Journal Article
Open access
KBKim L Bennell
Kim L Bennell
BLBelinda J Lawford
Belinda J Lawford
BMBen Metcalf
Ben Metcalf
DMDavid Mackenzie
David Mackenzie
TRTrevor Russell
Trevor Russell
RHRana S Hinman
Rana S Hinman
What were the experiences of physiotherapists and patients who consulted via videoconference during the COVID-19 pandemic and how was it implemented? Mixed methods study with cross-sectional national online surveys and qualitative analysis of free-text responses. A total of 207 physiotherapists in private practice or community settings and 401 patients aged ≥ 18 years who consulted (individual and/or group) via videoconference from April to November 2020. Separate customised online surveys were developed for physiotherapists and patients. Data were collected regarding the implementation of videoconferencing (cost, software used) and experience with videoconferencing (perceived effectiveness, safety, ease of use and comfort communicating, each scored on a 4-point ordinal scale). Qualitative content analysis was performed of physiotherapists' free-text responses about perceived facilitators, barriers and safety issues. Physiotherapists gave moderate-to-high ratings for the effectiveness of and their satisfaction with videoconferencing. Most intended to continue to offer individual consultations (81%) and group classes (60%) via videoconferencing beyond the pandemic. For individual consultations and group classes, respectively, most patients had moderately or extremely positive perceptions about ease of technology use (94%, 91%), comfort communicating (96%, 86%), satisfaction with management (92%, 93%), satisfaction with privacy/security (98%, 95%), safety (99% both) and effectiveness (83%, 89%). Compared with 68% for group classes, 47% of patients indicated they were moderately or extremely likely to choose videoconferencing for individual consultations in the future. Technology was predominant as both a facilitator and barrier. Falls risk was the main safety factor. Patients and physiotherapists had overall positive experiences using videoconferencing for individual consultations and group classes. The results suggest that videoconferencing is a viable option for the delivery of physiotherapy care in the future.

20 November 2019 in British Journal of Sports Medicine
Verified
Journal Article
Closed access
PDF file
RHRana S Hinman
Rana S Hinman
PCPenny K Campbell
Penny K Campbell
BLBelinda J Lawford
Belinda J Lawford
ABAndrew M Briggs
Andrew M Briggs
JGJanette Gale
Janette Gale
KBKim L Bennell
Kim L Bennell
Objective Evaluate a physiotherapist-led telephone-delivered exercise advice and support intervention for people with knee osteoarthritis. Methods Participant-blinded, assessor-blinded randomised controlled trial. 175 people were randomly allocated to (1) existing telephone service (≥1 nurse consultation for self-management advice) or (2) exercise advice and support (5–10 consultations with a physiotherapist trained in behaviour change for a personalised strengthening and physical activity programme) plus the existing service. Primary outcomes were overall knee pain (Numerical Rating Scale, range 0–10) and physical function (Western Ontario and McMaster Universities Osteoarthritis Index, range 0–68) at 6 months. Secondary outcomes, cost-effectiveness and 12-month follow-up were included. Results 165 (94%) and 158 (90%) participants were retained at 6 and 12 months, respectively. At 6 months, exercise advice and support resulted in greater improvement in function (mean difference 4.7 (95% CI 1.0 to 8.4)), but not overall pain (0.7, 0.0 to 1.4). Eight of 14 secondary outcomes favoured exercise advice and support at 6 months, including pain on daily activities, walking pain, pain self-efficacy, global improvements across multiple domains (overall improvement, improved pain, improved function and improved physical activity) and satisfaction. By 12 months, most outcomes were similar between groups. Exercise advice and support cost $A514/participant and did not save other health service resources. Conclusion Telephone-delivered physiotherapist-led exercise advice and support modestly improved physical function but not the co-primary outcome of knee pain at 6 months. Functional benefits were not sustained at 12 months. The clinical significance of this effect is uncertain. Trial registration number Australian New Zealand Clinical Trials Registry (#12616000054415).

1 February 2022 in Annals of Internal Medicine
Verified
Journal Article
Closed access
KBKim L. Bennell
Kim L. Bennell
BLBelinda J. Lawford
Belinda J. Lawford
CKCatherine Keating
Catherine Keating
CBCourtney Brown
Courtney Brown
JKJessica Kasza
Jessica Kasza
RHRana S. Hinman
Rana S. Hinman
Clinical guidelines recommend education, exercise, and weight management as first-line interventions for osteoarthritis. This randomized clinical trial studied the effectiveness of 2 potentially sc... Visual Telehealth-Delivered Osteoarthritis Exercise and Weight Loss Programs. Clinical guidelines recommend education, exercise, and weight management as first-line interventions for osteo... Background: Scalable knee osteoarthritis programs are needed to deliver recommended education, exercise, and weight loss interventions. Objective: To evaluate two 6-month, telehealth-delivered exer...

3 December 2024 in Cochrane Database of Systematic Reviews
Verified
Journal Article
Closed access
BLBelinda J Lawford
Belinda J Lawford
MHMichelle Hall
Michelle Hall
RHRana S Hinman
Rana S Hinman
MEMartin Van der Esch
Martin Van der Esch
AHAlison R Harmer
Alison R Harmer
KBKim L Bennell
Kim L Bennell


4 September 2025 in Osteoarthritis and Cartilage
Verified
Journal Article
Open access
ADAndrea Dell’iSola
Andrea Dell’iSola
FRFilippo Recenti
Filippo Recenti
Benedetto GiardulliBenedetto Giardulli
Benedetto Giardulli
BLBelinda J. Lawford
Belinda J. Lawford
AKAliasghar Ahmad Kiadaliri
Aliasghar Ahmad Kiadaliri
To summarise key epidemiological and therapeutic research on osteoarthritis (OA) published between April 2024 and March 2025. A narrative review was conducted using the MEDLINE database, focusing on English-language studies involving human participants published between April 1, 2024 and March 31, 2025. Eligible studies included observational longitudinal studies, systematic reviews, meta-analyses, and phase II-IV randomised controlled trials (RCTs) examining OA treatment and epidemiology. A total of 1920 studies were screened by 3 authors, resulting in 133 studies considered for potential inclusion. Ultimately, 41 studies were selected. Inclusion was based on perceived importance and relevance to identifying risk factors or advancing OA treatment. The global burden of OA continues to rise, with a notable increase in early-onset OA, driven in part by obesity and joint injuries. Epidemiologically, body composition-characterised by high fat mass and low lean mass-emerged as a critical factor influencing OA severity and physical function. Furthermore, the presence of other chronic conditions significantly impacts OA progression and outcomes, and influences management choice, increasing the risk of patients receiving low-value care. Therapeutic interventions for OA, including intra-articular injections (e.g., corticosteroids, hyaluronic acid, stem cells) and pharmacological therapies (e.g., metformin, methotrexate), continue to show limited efficacy. Semaglutide, which targets obesity, demonstrated substantial weight and pain reductions in individuals with knee OA and obesity, suggesting a potential disease-modifying effect through weight loss. The past year's research highlights the complexity of OA and the limited effectiveness of current interventions. While therapies targeting obesity hold promise, further research is needed to confirm their role in disease modification. Personalised treatment approaches that integrate metabolic, biomechanical, and psychosocial factors may be crucial for advancing OA care management.